Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3-4
|
pubmed:dateCreated |
1992-2-18
|
pubmed:abstractText |
The effect of increasing concentrations (from 0.01 to 10 micrograms/ml) of HIV-1 envelope glycoproteins gp160, gp120, gp41 and core protein p24 was evaluated on the in vitro growth of enriched hematopoietic progenitors (CD34+ cells). Both gp120 and gp160, at concentrations from 0.01 to 10 micrograms/ml, caused a progressive and significant (p less than 0.05) decrease in viable CD34+ cell count in liquid cultures supplemented with 2 ng/ml of human recombinant (r) interleukin-3 (IL-3), evaluated by means of Trypan-blue exclusion and [3H]thymidine ([3H]TdR) incorporation. In the absence of rIL-3, no inhibitory effects were observed even at the highest gp160 and gp120 concentrations explored (10 micrograms/ml). On the contrary, gp41 and p24 did not affect the number of viable CD34+ cells, either in the presence or in the absence of rIL-3. Moreover, gp160 and gp120, but not gp41 and p24, significantly (p less than 0.05) inhibited the in vitro growth of granulomacrophage progenitors (CFU-GM) in a dose-dependent fashion. These data clearly demonstrate that HIV-1 envelope glycoproteins inhibit the growth of purified hematopoietic progenitors. We propose that HIV-1 can impair hematopoiesis through the interaction of gp120/gp160 with CD34+ cell surface, independently of an infectious process.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD34,
http://linkedlifedata.com/resource/pubmed/chemical/Gene Products, env,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Envelope Protein gp120,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Envelope Protein gp160,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Precursors,
http://linkedlifedata.com/resource/pubmed/chemical/Retroviridae Proteins
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0304-8608
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
122
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
271-80
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1370604-Antigens, CD,
pubmed-meshheading:1370604-Antigens, CD34,
pubmed-meshheading:1370604-Cell Count,
pubmed-meshheading:1370604-Cell Division,
pubmed-meshheading:1370604-Cell Separation,
pubmed-meshheading:1370604-Cells, Cultured,
pubmed-meshheading:1370604-Gene Products, env,
pubmed-meshheading:1370604-HIV Envelope Protein gp120,
pubmed-meshheading:1370604-HIV Envelope Protein gp160,
pubmed-meshheading:1370604-HIV-1,
pubmed-meshheading:1370604-Hematopoiesis,
pubmed-meshheading:1370604-Hematopoietic Stem Cells,
pubmed-meshheading:1370604-Humans,
pubmed-meshheading:1370604-Protein Precursors,
pubmed-meshheading:1370604-Retroviridae Proteins
|
pubmed:year |
1992
|
pubmed:articleTitle |
Inhibitory effect of HIV-1 envelope glycoproteins gp120 and gp160 on the in vitro growth of enriched (CD34+) hematopoietic progenitor cells.
|
pubmed:affiliation |
Institute of Microbiology, University of Bologna, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|